BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27000503)

  • 1. Dose Tolerance for Stereotactic Body Radiation Therapy.
    Grimm J
    Semin Radiat Oncol; 2016 Apr; 26(2):87-8. PubMed ID: 27000503
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereotactic radiosurgery and radiation therapy for spinal tumors.
    Lo SS; Chang EL; Yamada Y; Sloan AE; Suh JH; Mendel E
    Expert Rev Neurother; 2007 Jan; 7(1):85-93. PubMed ID: 17187488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas.
    Daly ME; Choi CY; Gibbs IC; Adler JR; Chang SD; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):213-20. PubMed ID: 21481724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.
    Hiniker SM; Modlin LA; Choi CY; Atalar B; Seiger K; Binkley MS; Harris JP; Liao YJ; Fischbein N; Wang L; Ho A; Lo A; Chang SD; Harsh GR; Gibbs IC; Hancock SL; Li G; Adler JR; Soltys SG
    Semin Radiat Oncol; 2016 Apr; 26(2):97-104. PubMed ID: 27000505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction and Clinical Overview of the DVH Risk Map.
    Asbell SO; Grimm J; Xue J; Chew MS; LaCouture TA
    Semin Radiat Oncol; 2016 Apr; 26(2):89-96. PubMed ID: 27000504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Response Model for Chest Wall Tolerance of Stereotactic Body Radiation Therapy.
    Kimsey F; McKay J; Gefter J; Milano MT; Moiseenko V; Grimm J; Berg R
    Semin Radiat Oncol; 2016 Apr; 26(2):129-34. PubMed ID: 27000509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels.
    Xue J; Kubicek G; Patel A; Goldsmith B; Asbell SO; LaCouture TA
    Semin Radiat Oncol; 2016 Apr; 26(2):135-9. PubMed ID: 27000510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery.
    Leavitt JA; Stafford SL; Link MJ; Pollock BE
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):524-7. PubMed ID: 24074926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic principles of radiobiology, radiotherapy, and radiosurgery.
    Shrieve DC; Klish M; Wendland MM; Watson GA
    Neurosurg Clin N Am; 2004 Oct; 15(4):467-79, x. PubMed ID: 15450882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stereotactic ablative irradiation for lung cancer].
    Antoni D; Srour I; Noël G; Mornex F
    Cancer Radiother; 2014; 18(4):297-307. PubMed ID: 24907006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume effects on brainstem dose tolerance in radiosurgery.
    Xue J; Goldman HW; Grimm J; LaCouture T; Chen Y; Hughes L; Yorke E
    J Neurosurg; 2012 Dec; 117 Suppl():189-96. PubMed ID: 23205809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy.
    Yang J; Fowler JF; Lamond JP; Lanciano R; Feng J; Brady LW
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):903-9. PubMed ID: 20400240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of volume on the tolerance of the brain to radiosurgery.
    Marks LB; Spencer DP
    J Neurosurg; 1991 Aug; 75(2):177-80. PubMed ID: 2072155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose Constraints.
    Goldsmith C; Price P; Cross T; Loughlin S; Cowley I; Plowman N
    Semin Radiat Oncol; 2016 Apr; 26(2):149-56. PubMed ID: 27000512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stereotactic irradiation (Linac) for brain tumors].
    Shirato H; Aoyama H; Suzuki K; Miyasaka K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():419-24. PubMed ID: 16201557
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stereotactic body radiation therapy and oligometastases].
    Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
    Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal Dose Tolerance in Patients Treated With Stereotactic Body Radiation Therapy.
    Nuyttens JJ; Moiseenko V; McLaughlin M; Jain S; Herbert S; Grimm J
    Semin Radiat Oncol; 2016 Apr; 26(2):120-8. PubMed ID: 27000508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of stereotactic body radiotherapy and stereotactic radiosurgery in the re-irradiation of metastatic spinal tumors.
    Jain AK; Yamada YJ
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1141-52. PubMed ID: 25066490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.
    Kim DW; Cho LC; Straka C; Christie A; Lotan Y; Pistenmaa D; Kavanagh BD; Nanda A; Kueplian P; Brindle J; Cooley S; Perkins A; Raben D; Xie XJ; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):509-17. PubMed ID: 24929162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.